AKT1 and chronic obstructive pulmonary disease: In addition to some of these molecular targeted drugs, natural compounds, traditional Chinese medicine formulations, and some anti-inflammatory agents also inhibit the progression of COPD by inhibiting the PI3K/Akt pathway.